[1]Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern[J]. Lancet, 2020, 395: 470-473. [2]刘力. 新型冠状病毒SARS-CoV-2:高致病性及其防治[J]. 基础医学与临床,2020,40: 433-439. [3]程艳伟,操雪,秦历杰. 人冠状病毒跨种传播的研究进展[J]. 中华微生物学和免疫学杂志,2020,40: 146-153. [4]李晟,李妮蓉,刘玲玲,等. 新型冠状病毒肺炎的临床特征[J]. 基础医学与临床,2020,40: 593-597. [5]郭雅琼,张笠,鲁彦. 新型冠状病毒引起的临床相关疾病及其分子生物学检测[EB/OL].(2020-03-17) [2020-09-02]. http://kns.cnki.net/kcms/detail/50.1167.R.2020 0316.1810.002.html. [6]高维寅,张洪,罗阳.新型冠状病毒肺炎核酸检测中的假阴性分析及对策[EB/OL].(2020-03-04) [2020-09-02]. http://kns.cnki.net/kcms/detail/50.1176.R.20200304.1030.004.html. [7]Hogan CA, Sahoo MK, Pinsky BA. Sample pooling as a strategy to detect community transmission of SARS-CoV-2[J]. JAMA, 2020, 323: 1967-1969. [8]中国疾病预防控制中心. 新型冠状病毒肺炎实验室检测技术指南[EB/OL]. (2020-03-08) [2020-03-09]. [9]Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR[J]. Euro Surveill, 2020, 25: 23-30. |